# ProQuest Investments: portfolio, investments and team

> ProQuest Investments is a vc firm based in United States. 39 investments on record, latest Nov 2014. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/proquest-investments (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# ProQuest Investments

Last cheque observed Nov 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet VC firm

Series B Venture Series A Analytics Biotechnology SaaS

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 39 on record

Since the last cheque **4361** days **00** hrs **00** min **00** sec

Median round **$30M** Rounds led **0 of 39** Sole investor **1 rounds** Exits **12 from the portfolio** Mostly in **United States, 84%**

Pitch ProQuest Investments

## ProQuest Investments highlights

- 01 39 rounds on record
- 02 Mostly Series B and Venture: 49% of its rounds
- 03 Sole investor in 1 rounds, median $17M
- 04 12 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Analytics Biotechnology SaaS
- **Based in:** Princeton, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **39 appearances**

- **2014** 2 rounds
- **Nov** **[SomaLogic](https://millionrounds.com/company/somalogic)** Venture · US **$17M** Sole investor
- **Aug** **[Mevion Medical Systems](https://millionrounds.com/company/mevion-medical-systems)** Growth · US **$200M** With 5 others
- **2013** 5 rounds
- **Dec** **[Telormedix](https://millionrounds.com/company/telormedix)** Series B · CH · unquote.com **$7.9M** With 1 other
- **Oct** **[Immune Design](https://millionrounds.com/company/immune-design)** Series C · US · finsmes.com **$49M** With 6 others
- **Jul** **[ReVision Optics](https://millionrounds.com/company/revision-optics)** Series E · US · finsmes.com **$55M** With 5 others
- **Jun** **[Mevion Medical Systems](https://millionrounds.com/company/mevion-medical-systems)** Growth · US · finsmes.com **$55M** With 3 others
- **Apr** **[ReVision Optics](https://millionrounds.com/company/revision-optics)** Series E · US · sec.gov **$15M** With 4 others
- **2012** 4 rounds
- **Jul** **[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)** Series A · US · finsmes.com **$27M** With 4 others
- **Jul** **[Agile Therapeutics](https://millionrounds.com/company/agile-therapeutics)** Series C · US · finsmes.com **$40M** With 5 others
- **Feb** **[Telormedix](https://millionrounds.com/company/telormedix)** Series B · CH · onbiovc.com **$8.3M** With 1 other
- **Jan** **[Mevion Medical Systems](https://millionrounds.com/company/mevion-medical-systems)** Venture · US · mevion.com **$45M** With 2 others
- **2011** 1 round
- **Sept** **[MethylGene](https://millionrounds.com/company/methylgene)** Venture · CA · sec.gov **$35M** With 2 others
- **2010** 4 rounds
- **Jul** **[Immune Design](https://millionrounds.com/company/immune-design)** Series B · US · xconomy.com **$32M** With 4 others
- **Jul** **[ReVision Optics](https://millionrounds.com/company/revision-optics)** Series D · US · onbiovc.com **$35M** With 3 others
- **Jun** **[Predictive Biosciences](https://millionrounds.com/company/predictive-biosciences)** Series C · US · onbiovc.com **$25M** With 4 others
- **Apr** **[Tragara](https://millionrounds.com/company/tragara)** Series B · US · onbiovc.com **$5.0M** With 4 others
- **2009** 7 rounds
- **Aug** **[Gloucester Pharmaceuticals](https://millionrounds.com/company/gloucester-pharmaceuticals)** Series D · US · gloucesterpharma.com **$29M** With 4 others
- **Aug** **[Biosyntech](https://millionrounds.com/company/biosyntech)** Venture · CA · biosyntech.com **$1.4M** With 3 others
- **Aug** **[Zosano Pharma](https://millionrounds.com/company/zosano-pharma)** Series B · US · onbiovc.com **$30M** With 3 others
- **May** **[Clovis Oncology](https://millionrounds.com/company/clovis-oncology)** Growth · US **$145M** With 6 others
- **May** **[Clovis Oncology](https://millionrounds.com/company/clovis-oncology)** Series A · US · onbiovc.com **$145M** With 6 others
- **Apr** **[Orthocon](https://millionrounds.com/company/orthocon)** Series B · US · pehub.com **$25M** With 2 others
- **Apr** **[Aerovance](https://millionrounds.com/company/aerovance)** Venture · US · venturebeat.com **$38M** With 7 others
- **2008** 1 round
- **Jul** **[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Series C · CA · siliconindia.com **$38M** With 12 others
- **2007** 4 rounds
- **Nov** **[Excaliard Pharmaceuticals](https://millionrounds.com/company/excaliard-pharmaceuticals)** Series A · US · excaliard.com **$16M** With 2 others
- **Nov** **[Zosano Pharma](https://millionrounds.com/company/zosano-pharma)** Series A · US · zosanopharma.com **$90M** With 3 others
- **Nov** **[LEAD Therapeutics](https://millionrounds.com/company/lead-therapeutics)** Series A · US · leadtherapeutics.com **$17M** With 2 others
- **Mar** **[Tragara](https://millionrounds.com/company/tragara)** Series A · US **$40M** With 4 others
- **2005** 3 rounds
- **Dec** **[Optimer Pharmaceuticals](https://millionrounds.com/company/optimer-pharmaceuticals)** Series D · US **$22M** With 7 others
- **Nov** **[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)** Venture · US · mersana.com **$21M** With 7 others
- **Jul** **[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Venture · GB **$14M** With 1 other
- **2004** 4 rounds
- **Sept** **[Sopherion Therapeutics](https://millionrounds.com/company/sopherion-therapeutics)** Series B · US **$47M** With 7 others
- **Mar** **[BioRexis](https://millionrounds.com/company/biorexis)** Series B **$30M** With 6 others
- **Jan** **[Threshold Pharmaceuticals](https://millionrounds.com/company/threshold-pharmaceuticals)** Series B · US **$41M** With 6 others
- **Jan** **[Novacea](https://millionrounds.com/company/novacea)** Series C · US **$35M** With 5 others
- **2003** 1 round
- **Mar** **[Sopherion Therapeutics](https://millionrounds.com/company/sopherion-therapeutics)** Series A · US **$26M** With 7 others
- **2002** 2 rounds
- **Dec** **[BioRexis](https://millionrounds.com/company/biorexis)** Series A **$8.0M** With 2 others
- **Oct** **[Pharmion](https://millionrounds.com/company/pharmion)** Venture · US **$40M** With 5 others
- **2001** 1 round
- **Jun** **[Guava Technologies](https://millionrounds.com/company/guava-technologies)** Series B · US **$18M** With 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **3** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **12 in all**

**[Optimer Pharmaceuticals](https://millionrounds.com/company/optimer-pharmaceuticals)** Bought by [Cubist Pharmaceuticals](https://millionrounds.com/fund/cubist-pharmaceuticals) **$535M** Jul 2013

**[MethylGene](https://millionrounds.com/company/methylgene)** Bought by Mirati Therapeutics Inc. **Undisclosed** Jun 2013

**[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Bought by [Jazz Pharmaceuticals](https://millionrounds.com/fund/jazz-pharmaceuticals) **$650M** Apr 2012

**[Excaliard Pharmaceuticals](https://millionrounds.com/company/excaliard-pharmaceuticals)** Bought by Excaliard Pharmaceuticals **Undisclosed** Nov 2011

**[Clovis Oncology](https://millionrounds.com/company/clovis-oncology)** Listed **$130M** Nov 2011

**[Gemin X Pharmaceuticals](https://millionrounds.com/company/gemin-x-pharmaceuticals)** Bought by [Cephalon](https://millionrounds.com/fund/cephalon) **$525M** Mar 2011

**[Gloucester Pharmaceuticals](https://millionrounds.com/company/gloucester-pharmaceuticals)** Bought by [Celgene](https://millionrounds.com/fund/celgene) **$640M** Dec 2009

**[Guava Technologies](https://millionrounds.com/company/guava-technologies)** Bought by Millipore **$23M** Feb 2009

**[EUSA Pharma](https://millionrounds.com/company/eusa-pharma)** Bought by EUSA Pharma **$23M** Mar 2008

**[Pharmion](https://millionrounds.com/company/pharmion)** Bought by [Celgene](https://millionrounds.com/fund/celgene) **$2.9B** Nov 2007

**[BioRexis](https://millionrounds.com/company/biorexis)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Feb 2007

**[Threshold Pharmaceuticals](https://millionrounds.com/company/threshold-pharmaceuticals)** Listed **Undisclosed** Jan 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series B Venture Series A

Median round joined **$30M** the round, not its cheque Alone, median **$17M**

Led 0 of 39 rounds **0%**

- **Sole investor:** 1 rounds
- **Last cheque:** Nov 2014
- **Exits:** 12 from the portfolio

Rounds by stage said on their site

- Series B *10*
- Venture *8*
- Series A *8*
- Series C *5*
- Series D *3*
- Growth *3*

Cheques by year Led Joined

2001 2014

Often in the room with

- [Domain Associates](https://millionrounds.com/fund/domain-associates) 8
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 8
- [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 6
- [Canaan](https://millionrounds.com/fund/canaan-partners) 5
- [Alta Partners](https://millionrounds.com/fund/alta-partners) 4
- [CHL Medical Partners](https://millionrounds.com/fund/chl-medical-partners) 4

**Pitching ProQuest Investments?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as ProQuest Investments. A count of rooms they were both in, not a relationship either has claimed.

[**Domain Associates** VC firm **8** rounds together](https://millionrounds.com/fund/domain-associates)[**New Enterprise Associates** VC firm **8** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Versant Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/versant-ventures)[**Canaan** VC firm **5** rounds together](https://millionrounds.com/fund/canaan-partners)[**Alta Partners** VC firm **4** rounds together](https://millionrounds.com/fund/alta-partners)[**CHL Medical Partners** VC firm **4** rounds together](https://millionrounds.com/fund/chl-medical-partners)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **4** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**Abingworth** VC firm **3** rounds together](https://millionrounds.com/fund/abingworth)[**BB Biotech Ventures** Growth equity **3** rounds together](https://millionrounds.com/fund/bb-biotech-ventures)[**Caxton Advantage Life Sciences Fund** Growth equity **3** rounds together](https://millionrounds.com/fund/caxton-advantage-life-sciences-fund)[**Fonds de solidarite Ftq** VC firm **3** rounds together](https://millionrounds.com/fund/fonds-de-solidarite-ftq)[**Morgenthaler Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/morgenthaler)

## Quick answers about ProQuest Investments

### What does ProQuest Investments invest in?

ProQuest Investments invests most often at Series B and Venture (49% of the rounds on record), in sectors such as Analytics, Biotechnology and SaaS.

### How active is ProQuest Investments?

39 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2014.

### How big are ProQuest Investments's cheques?

The median round it joins is $30M.

### Does ProQuest Investments lead rounds?

Rarely, if at all: none of its 39 investments on record names it as the lead.

### Where does ProQuest Investments invest?

Most of the companies it backs are in the United States (84%), Canada (8%) and Switzerland (5%).

### Is ProQuest Investments investing now?

No investments in the last 12 months; the latest was in Nov 2014.

### Who does ProQuest Investments invest alongside?

Most often Domain Associates (8 rounds together), New Enterprise Associates (8 rounds together) and Versant Ventures (6 rounds together).

### What kind of investor is ProQuest Investments?

ProQuest Investments is a VC firm based in Princeton, United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=proquest-investments) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=proquest-investments)